Home/Filings/4/0001213900-24-086271
4//SEC Filing

Sturge Simon 4

Accession 0001213900-24-086271

CIK 0001821586other

Filed

Oct 7, 8:00 PM ET

Accepted

Oct 8, 4:01 PM ET

Size

5.1 KB

Accession

0001213900-24-086271

Insider Transaction Report

Form 4
Period: 2024-10-04
Sturge Simon
Director
Transactions
  • Sale

    Class A ordinary shares, par value $0.0001 per share

    2024-10-04$53.72/sh171,000$9,186,120171,980 total
Footnotes (1)
  • [F1]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $53.00 to $55.34. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Documents

1 file

Issuer

MoonLake Immunotherapeutics

CIK 0001821586

Entity typeother

Related Parties

1
  • filerCIK 0001920785

Filing Metadata

Form type
4
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:01 PM ET
Size
5.1 KB